After years of battling, Vertex and the U.K. reach a deal for cystic fibrosis medicines

After years of frustration, Vertex (VRTX) Pharmaceuticals struck a deal with the U.K. government to supply its cystic fibrosis medicines, capping an end to a dispute that had become a symbol of the growing clash between cash-strapped governments and drug makers over the rising prices for medicines.